Sanford Simon biography
Dr. Sanford R. Simon, Ph.D., is an Independent Director of the company. Dr. Simon has been a Professor of Biochemistry, Cell Biology and Pathology at Stony Brook since 1997. He joined the faculty at Stony Brook as an Assistant Professor in 1969 and was promoted to Associate Professor with tenure in 1975. Dr. Simon was a member of the Board of Directors of The Collaborative Group from 1995 to 2004. From 1967 to 1969 Dr. Simon was a Guest Investigator at Rockefeller University. Dr. Simon received a B.A. in Zoology and Chemistry from Columbia University in 1963, a Ph.D. in Biochemistry from Rockefeller University in 1967, and studied as a postdoctoral fellow with Nobel Prize winner Max Perutz in Cambridge, England. He maintains an active research laboratory studying aspects of cell invasion in cancer and inflammation and novel strategies of drug delivery; he also teaches undergraduate, graduate, medical and dental students.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
How old is Sanford Simon?
Sanford Simon is 72, he's been the Independent Director of Applied Dna Sciences Inc since 2006. There are 1 older and 13 younger executives at Applied Dna Sciences Inc. The oldest executive at Applied Dna Sciences Inc is Robert Catell, 80, who is the Director.
What's Sanford Simon's mailing address?
Sanford's mailing address filed with the SEC is 50, Health Sciences Drive, Stony Brook University, Suffolk, New York, 11794, United States.
Insiders trading at Applied Dna Sciences Inc
Over the last 21 years, insiders at Applied Dna Sciences Inc have traded over $13,655,198 worth of Applied Dna Sciences Inc stock and bought 12,115,698 units worth $17,246,871 . The most active insiders traders include Management Inc Rhl, Lawrence Lee, and Dwyer Management Inc O. On average, Applied Dna Sciences Inc executives and independent directors trade stock every 59 days with the average trade being worth of $312,035. The most recent stock trade was executed by Scott L Anchin on 10 March 2021, trading 13,049 units of APDN stock currently worth $110,003.
What does Applied Dna Sciences Inc do?
we keep life real and safe by providing botanical-dna based security and authentication solutions and services that protect assets, products, brands, supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion.
What does Applied Dna Sciences Inc's logo look like?
Applied Dna Sciences Inc executives and stock owners
Applied Dna Sciences Inc executives and other stock owners filed with the SEC include:
-
James Hayward,
Chairman of the Board, President, Chief Executive Officer -
Dr. James A. Hayward Ph.D., Sc.D.,
Chairman, Pres & CEO -
Ming-Hwa Liang,
Secretary, Strategic Technology Development Officer -
Judith Murrah,
Chief Information Officer -
Beth Jantzen,
Chief Financial Officer -
Judith Murrah,
COO, Chief Information Officer & Sec. -
Beth M. Jantzen CPA, CPA,
Chief Financial Officer -
Scott L. Anchin,
Strategic Advisor & Independent Director -
Sanford Simon,
Independent Director -
Yacov Shamash,
Independent Director -
Joseph Ceccoli,
Independent Director -
John Bitzer,
Independent Director -
Scott Anchin,
Independent Director -
Elizabeth Ferguson,
Director -
Robert Catell,
Director -
Clay Shorrock Esq., J.D.,
Chief Legal Officer & Exec. Director of Bus. Devel. -
MeiLin Wan,
VP of Textile Sales -
Janice Meraglia,
VP, Gov. & Military Programs -
Tony Benson,
Managing Director of EMEA -
John Shearman,
Exec. Director of Marketing & Cannabis Bus. -
Clay Shorrock Esq.,
Gen. Counsel -
Sanjay M. Hurry,
Exec. Director of Investor Relations & Corp. Communications -
Michael E Hill,
Director -
Jaime A Cardona,
Secretary -
Charles S. Ryan,
Director -
Dwyer Management Inc O,
-
Glenn Little,
10% owner -
Gerhard H Wehr,
CFO -
Lawrence Lee,
President, CEO -
Management Inc Rhl,
10% owner -
Elizabeth M Schmalz,
Director -
William W Montgomery,
-
Karol Gray,
Chief Financial Officer -
Yacov Shamash,
Director -
Rick Langley,
10% owner -
Clay Shorrock,
Chief Legal Officer